At Barron's cover image

At Barron's

Pfizer CEO Bourla on R&D, Obesity Drugs, and Winning Back Investors

Jan 18, 2024
20:58

Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth."

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app